Background: Increasing numbers of patients have recovered from severe coronavirus disease 2019 in Wuhan, China. This study aimed to evaluate the association of psychological distress with resting palpitations in recovered patients. Methods: In this prospective cohort study, consecutive patients who recovered from severe COVID-19 and complained of resting palpitations were included. Dynamic electrocardiogram (ECG) was continuously monitored for 2 hours while patients were at rest. A survey using a palpitation frequency scale and the Hospital Anxiety and Depression Scale (HADS) was administered to all participants. Results: Of the 289 consecutive patients who recovered from severe COVID-19, 24 patients (8.3%) suffered resting palpitation symptoms, and 22 patients were finally included. Twohour Holter monitoring showed that 18 (81.8%) patients had tachyarrhythmias, of which the most common was sinus tachycardia (17/22, 77.3%). However, patients with sinus tachycardia showed a similar frequency of palpitation episodes compared to those without sinus tachycardia. Anxiety (68.2%) and depression (59.1%) were prevalent among these recovered patients. Patients with anxiety or depression symptoms had a higher frequency of palpitation episodes than those without anxiety or depression symptoms. In addition, both the HADSanxiety score (r =0.609, P<0.01) and HADS-depression score (r =0.516, P=0.01) were positively related to the frequency of palpitation episodes. Conclusion: Symptoms of resting palpitations, manifested mainly by sinus tachycardia, are not uncommon in patients who recovered from severe COVID-19. Psychological distress (anxiety and depression) may be responsible, at least in part, for resting palpitation symptoms.
Background: Increasing numbers of patients have recovered from severe coronavirus disease 2019 in Wuhan, China. This study aimed to evaluate the association of psychological distress with resting palpitations in those recovered patients. Methods: In this prospective cohort study, consecutive patients who recovered from severe COVID-19 and complained of resting palpitations were included. Dynamic electrocardiogram (ECG) was continuously monitored for 2 hours while patients were at rest. A survey using palpitation frequency scale and the Hospital Anxiety and Depression Scale (HADS) was administrated to all participants. Results: Of the 289 consecutive patients recovering from severe COVID-19, 24 patients (8.3%) suffered resting palpitations symptoms, and 22 patients were finally included. Dynamic ECG monitoring showed that 18 (81.8%) patients had tachyarrhythmias, of which, the most common was sinus tachycardia (17/22, 77.3%). However, patients with sinus tachycardia showed a similar frequency of palpitations episodes compared to those without sinus tachycardia. Anxiety (68.2%) and depression (59.1%) were prevalent among these recovered patients. Patients with anxiety or depression symptoms were respectively associated with a higher frequency of palpitations episodes than those without. In addition, both HADS-anxiety score (r =0.609, P<0.01) and HADS-depression score (r =0.516, P=0.01) were positively related to the frequency of palpitations episodes, respectively. Conclusion: Symptom of resting palpitations, manifested mainly by sinus tachycardia, is not uncommon in patients recovering from severe COVID-19. Psychological distress (anxiety and depression) may be responsible, at least in part, for the resting palpitations symptoms.Recently, several studies have focused on the mental health in COVID-19 patients. The results found that a majority of the infected patients experienced various mental disturbances during hospitalization and even
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.